TABLE 1.
Type of beads | Fusion protein immobilization treatment | Incubation temp (°C) | % of sporesb
|
Total (%) | ||
---|---|---|---|---|---|---|
Unbound | Bound but removed by washing | Bound | ||||
Biotinylatedc | + | 23 | 1.7 (0.6) | 0.3 (0.2) | 98.0 (0.8) | 100 |
Biotinylated | + | 4 | 9.3 (3.4) | 0.7 (0.2) | 90.0 (3.6) | 100 |
Biotinylated | − | 4 | 99.3 (0.5) | 0.6 (0.4) | 0.1 (0.08) | 100 |
Biotinylated | − | 23 | 98.6 (0.6) | 1.3 (0.6) | 0.1 (0.6) | 100 |
Originald | − | 23 | 94.3 (3.4) | 5.0 (3.0) | 0.7 (0.5) | 100 |
Original | + | 23 | 64.4 (7.8) | 32.4 (7.1) | 3.2 (1.6) | 100 |
Spore concentration, 5 × 104 spores/ml; incubation time, 60 min.
Averages from three trials (numbers in parentheses are standard deviations).
Commercial sheep anti-mouse IgG-coated magnetic beads which were biotinylated as described in Materials and Methods.
Commercial sheep anti-mouse IgG-coated magnetic beads.